Medically reviewed by Erika Prouty, PharmD Key Takeaways There are two types of complement 3 glomerulopathy: dense deposit ...

Akebia Therapeutics is refocusing on Vafseo for dialysis patients, discontinuing expansion to non-dialysis, which has reset ...

What they've accomplished so far: The Rays have traded major players -- Shane Baz, Brandon Lowe, and Jake Mangum -- in two ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), ...

ASHLAND — As questions remain about the future management of the Paramount Arts Center and the forthcoming conference center, the proposed operators presented Ashland City Commissioners with ...

(RTTNews) - Biotechnology company Q32 Bio, Inc. (QTTB) announced Monday it has sold its Phase 2 complement inhibitor, ADX-097, to Akebia Therapeutics, Inc. (AKBA). ADX-097, the lead product candidate ...

-- $12 million in upfront and guaranteed near-term milestone payments expected to extend cash runway into the second half of 2027 -- -- Eligible to receive up to a total of $592 million including the ...

Daniel is a News Writer from the United Kingdom. Relatively new to the industry with almost three years of experience, he has focused on establishing himself in the gaming space. While he focuses on ...

The Outer Worlds 2 update 1.0.5.0 is here, saving our eyebrows and proving that the devs are keeping a close eye on Reddit, with one niche change potentially a direct response to a post on the site.

It had taken Bungie seven years of trial and error to land on systems for loot, leveling, investment and currency in Destiny 2 that were somewhat balanced and ...